Palmer Denise G
Maternal-Fetal Medicine Service, University of Minnesota Medical Center Fairview, Riverside Campus, MB 450, 2450 Riverside Ave, Minneapolis, MN 55454, USA.
J Perinat Neonatal Nurs. 2006 Oct-Dec;20(4):324-32. doi: 10.1097/00005237-200610000-00011.
Peripartum cardiomyopathy is a rare and potentially lethal cardiac complication of pregnancy occurring in the final month of pregnancy through the first 5 months after birth. It is characterized by the development of congestive heart failure and left ventricular systolic dysfunction, in previously healthy women with no other identifiable cause for heart failure. The etiology of peripartum cardiomyopathy is not well understood. Potential causal mechanisms include infection, autoimmune disease, and abnormal response to the hemodynamic stresses of pregnancy. There is significant risk of reoccurrence in subsequent pregnancies. The purpose of this article is to review the pathophysiology, diagnosis, management, prognosis, and nursing implications of peripartum cardiomyopathy.
围产期心肌病是一种罕见且可能致命的妊娠心脏并发症,发生在妊娠最后一个月至产后前5个月。其特征是在既往健康、无其他可识别的心力衰竭病因的女性中出现充血性心力衰竭和左心室收缩功能障碍。围产期心肌病的病因尚不完全清楚。潜在的致病机制包括感染、自身免疫性疾病以及对妊娠血流动力学应激的异常反应。后续妊娠有显著的复发风险。本文旨在综述围产期心肌病的病理生理学、诊断、管理、预后及护理要点。